MedPath

A Case-control Study to Assess the Association Between Environmental, Domestic and Occupational Exposures and the Risk of Testicular Germ Cell Tumor

Completed
Conditions
Testicular Germ Cell Tumor
Interventions
Other: Phone interview and blood test
Registration Number
NCT02109926
Lead Sponsor
Centre Leon Berard
Brief Summary

The incidence of testicular germ cell tumors, the most common cancer in men aged 15 to 45 years, has doubled in France in 30 years. Reasons remain unclear but a role of environmental factors, especially during critical periods of development, is strongly suspected. Reliable data on environmental exposure during this critical period are sparse.The discordant findings and the limitations of available studies underline the importance to conduct studies with sufficient statistical power to detect risk due to exposures during critical windows of vulnerability.

We conduct a multicentric case-control study to assess this association. Cases and controls will be enrolled during a 18-month period. They will be interviewed by professional telephone interviewers about their occupational and residential history and about their domestic exposure to pesticides and other nuisances.

An optional biological study to assess genetic polymorphisms known to be associated with testicular cancer will be proposed to every cases and controls.

Mothers (or close relative) of cases and controls will also be contacted (with son's agreement). If they agree to participate, they will also be interviewed about antenatal and early life exposure of their sons to pesticides and other nuisances.

Cases will be matched up with 2 controls (one of each group) both on age (+/- 2 years) and on recruiting center.

Detailed Description

Environmental exposure to pesticides will be assessed from subject's residential history, using a Geographic Information System.

Occupational exposure to pesticides and other nuisances will be assessed by an industrial hygienist who will be in charge to encode all subjects and mothers' occupations.

Domestic exposure to pesticides will be assessed from type, target and frequency of domestic pesticide use.

Based on these 3 sources of exposure, a score of exposition will be calculated for each case and each control.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
1367
Inclusion Criteria
  • Men aged between 18 and 44 years old
  • Born in metropolitan France
  • Able to understand, read and write French
  • Without any psychiatric and severe cognitive disorder
  • Willingness to participate to the study
  • Who has signed and dated an inform consent form
  • Affiliated to a health care system
Exclusion Criteria
  • Who has a legal guardian
  • History of testicular germ cell tumor or cryptorchidism (only for controls)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Cases: testicular cancer patientsPhone interview and blood test-
Group B controlsPhone interview and blood testHusbands of women with a pathological pregnancy
Group A controlsPhone interview and blood testSperm donors and husbands of women with fertility disorders All controls must have a normal spermogram
Primary Outcome Measures
NameTimeMethod
Assess the association between pesticide exposure during Antenatal and Early Postnatal Periods and the risk of testicular cancer during adulthoodat the end of enrollment (18 months)

Occupational, environmental and domestic exposures to pesticides and other nuisances will be assessed.

Secondary Outcome Measures
NameTimeMethod
Assess the association between a combined exposure to pesticides and the risk of testicular cancer during adulthoodat the end of enrollment (18 months)

The association will be assessed during antenatal, postnatal early life and later life (adolescence and adulthood).

Occupational, environmental and domestic exposures to pesticides and other nuisances will be assessed.

Analyse polymorphisms known to be associated with testicular cancer risk to explore gene-environment interactionsone year after the end of enrollment

Polymorphisms involved in organochlorine metabolism pathways will also be assessed.

Biological study

Trial Locations

Locations (22)

CHU de Caen

馃嚝馃嚪

Caen, France

CHU de Grenoble - H么pital Couple Enfants

馃嚝馃嚪

Grenoble, France

CHRU Jean Minjoz

馃嚝馃嚪

Besan莽on, France

CHU Jean Verdier

馃嚝馃嚪

Bondy, France

Maternit茅 CHU Pellegrin

馃嚝馃嚪

Bordeaux, France

H么pital Femme M猫re Enfant

馃嚝馃嚪

Bron, France

CHU Estaing

馃嚝馃嚪

Clermont-Ferrand, France

H么pital Cochin

馃嚝馃嚪

Paris, France

CHU Dijon

馃嚝馃嚪

Dijon, France

Centre L茅on B茅rard

馃嚝馃嚪

Lyon, France

CHRU Lille - H么pital Calmette

馃嚝馃嚪

Lille, France

CHU La Conception

馃嚝馃嚪

Marseille, France

H么pital Arnaud de Villeneuve

馃嚝馃嚪

Montpellier, France

Maternit茅 Universit茅 R茅gionale

馃嚝馃嚪

Nancy, France

CHU de Nice - H么pital l'Archet

馃嚝馃嚪

Nice, France

H么pital Tenon

馃嚝馃嚪

Paris, France

H么pital Maison Blanche

馃嚝馃嚪

Reims, France

CHU de Rennes - H么pital Sud

馃嚝馃嚪

Rennes, France

CHU Charles Nicolle

馃嚝馃嚪

Rouen, France

Centre M茅dico-Chirurgical Obst茅trique

馃嚝馃嚪

Schiltigheim, France

CHU Bretonneau

馃嚝馃嚪

Tours, France

H么pital Paule de Viguier

馃嚝馃嚪

Toulouse, France

漏 Copyright 2025. All Rights Reserved by MedPath